Page 1 | Search Results | Blood | American Society of Hematology

1-14 of 14

Sort by

Sort Order Select

Journal Articles

A Retrospective Comparison of Once-Daily Prolonged-Release Tacrolimus Versus Twice-Daily Tacrolimus in Allogeneic Bone Marrow Transplantation from Unrelated Donors

Shingo Yano, Takeshi Saito, MD, Hiroki Yokoyama, MD, Tomohito Machishimia, MD, Takaki Shimada, MD, Yuichi Yahagi, MD PhD, Shinobu Takahara, MD, Yoji Ogasawara, MD PhD, Katsuki Sugiyama, MD, Jiro Minami, MD, Yutaro Kamiyama, MD, Atsushi Katsube, MD, Noriyuki Morikawa, MD, Kazuhito Suzuki, MD, Yumiko Inui, MD, Noriko Usui, Keisuke Aiba, MD, PhD

Blood (2014) 124 (21): 5867.

https://doi.org/10.1182/blood.V124.21.5867.5867

Published: 2014

Journal Articles

Antitumor Activities Of An Oral Selective HSP90α/β Inhibitor, TAS-116, In Combination With Bortezomib In Multiple Myeloma

Rikio Suzuki, MD, PhD, Teru Hideshima, MD, PhD, Shuichi Ohkubo, PhD, Naoya Mimura, MD, PhD, Jiro Minami, MD, PhD, Hiroto Ohguchi, MD, PhD, Shohei Kikuchi, MD, PhD, Diana D. Cirstea, Francesca Cottini, MD, Dharminder Chauhan, PhD, Paul G. Richardson, MD, Nikhil C. Munshi, MD, Teruhiro Utsugi, PhD, Kenneth C. Anderson, MD

Blood (2013) 122 (21): 4429.

https://doi.org/10.1182/blood.V122.21.4429.4429

Published: 2013

Journal Articles

TAS-117, a Novel Selective Akt Inhibitor Demonstrates Significant Growth Inhibition in Multiple Myeloma Cells in Vitro and in Vivo

Naoya Mimura, Hiroto Ohguchi, Diana Cirstea, MD, Francesca Cottini, Gullu Topal Gorgun, PhD, Jiro Minami, Rikio Suzuki, Toshiyasu Shimomura, PhD, Teruhiro Utsugi, PhD, Teru Hideshima, MD, PhD, Kenneth C. Anderson, MD

Blood (2012) 120 (21): 942.

https://doi.org/10.1182/blood.V120.21.942.942

Published: 2012

Journal Articles

Rational Combination Treatment of a Novel Selective mTOR Kinase Inhibitor AZD8055 with IGF-1R Inhibitors in Multiple Myeloma

Diana Cirstea, Teru Hideshima, MD, PhD, Loredana Santo, Homare Eda, Tyler A. Scullen, Neeharika Nemani, Anuj Mahindra, Andrew Yee, Yiguo Hu, Naoya Mimura, Jiro Minami, Hiroto Ohguchi, Rikio Suzuki, Francesca Cottini, Sylvie M Guichard, Kenneth C. Anderson, Noopur Raje

Blood (2012) 120 (21): 4023.

https://doi.org/10.1182/blood.V120.21.4023.4023

Published: 2012

Journal Articles

Blockade of XBP1 splicing by inhibition of IRE1α is a promising therapeutic option in multiple myeloma

Blood (2012) 119 (24): 5772–5781.

https://doi.org/10.1182/blood-2011-07-366633

Published: 2012

Includes: Supplemental data

Journal Articles

Immunomodulatory Effects of Histone Deacetylase 6 Inhibition in Suppressor Immune Cells in Multiple Myeloma

Gullu Gorgun, PhD, Teru Hideshima, MD, PhD, Noopur S. Raje, MD, Naoya Mimura, MD, PhD, James E. Bradner, MD, Diana Cirstea, MD, Loredana Santo, MD, Yu-Tzu Tai, PhD, Michael Sellitto, Yiguo Hu, PhD, Claire Fabre, MD, PhD, Hiroto Ohguchi, MD, PhD, Jiro Minami, MD, PhD, Paul G. Richardson, MD, Nikhil C. Munshi, MD, Kenneth C. Anderson, MD

Blood (2011) 118 (21): 128.

https://doi.org/10.1182/blood.V118.21.128.128

Published: 2011

Journal Articles

Blockade of XBP1 Splicing by Inhibition of IRE1α Is a Promising Therapeutic Option in Multiple Myeloma

Blood (2011) 118 (21): 133.

https://doi.org/10.1182/blood.V118.21.133.133

Published: 2011

Journal Articles

Dual Inhibition of Canonical and Non-Canonical NF-KB Pathway Demonstrates Significant Anti-Tumor Activities in Multiple Myeloma (MM)

Claire Fabre, MD, PhD, Naoya Mimura, MD, PhD, Kathryn Bobb, MS, Gullu Gorgun, PhD, Diana D. Cirstea, MD, Yiguo Hu, PhD, Jiro Minami, MD, PhD, Hiroto Ohguchi, MD, PhD, Jie Zhang, PhD, Jeffrey Meshulam, BS, Constantine S. Mitsiades, MD, PhD, Paul G. Richardson, MD, Teru Hideshima, MD, PhD, Kenneth C. Anderson, MD

Blood (2011) 118 (21): 2902.

https://doi.org/10.1182/blood.V118.21.2902.2902

Published: 2011

Journal Articles

DEPTOR Is a Regulator of Response to mTOR Kinase Inhibitors in Multiple Myeloma

Diana Cirstea, MD, Teru Hideshima, MD, PhD, Loredana Santo, MD, Homare Eda, MD, PhD, Miriam Canavese, PhD, Tyler A. Scullen, BA, Anuj K. Mahindra, MD, Gullu Gorgun, PhD, Yiguo Hu, MD, PhD, Naoya Mimura, MD, PhD, Claire Fabre, MD, PhD, Jiro Minami, MD, PhD, Hiroto Ohguchi, MD, PhD, Kenneth C. Anderson, MD, Sylvie M Guichard, PharmD, PhD, Noopur S. Raje, MD

Blood (2011) 118 (21): 2916.

https://doi.org/10.1182/blood.V118.21.2916.2916

Published: 2011

Journal Articles

Single-Institute Comparable Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation from Unrelated and Related Donor in Patients with Myeloid Malignancies.

Shingo Yano, MD, Noriko Usui, MD, Nobuaki Dobashi, MD, Yutaka Takei, MD, Yuichi Yahagi, MD, Shinobu Takahara, MD, Hiroko Otsubo, MD, Yuko Yamaguchi, MD, Kinuyo Kasama, MD, Jiro Minami, MD, Tatsunosuke Kobayashi, MD, Yasutaka Hoshi, MD, Tadashi Kobayashi, MD, Osamu Asai, MD, Keisuke Aiba, MD

Blood (2007) 110 (11): 4946.

https://doi.org/10.1182/blood.V110.11.4946.4946

Published: 2007

Journal Articles

Role of Intensive Conditioning Regimens Followed by Allogeneic Stem Cell Transplantation in Patients with Acute Lymphoblastic Leukemia: A Long-Term Follow-Up.

Jiro Minami, MD, Osamu Asai, MD, Nobuaki Dobashi, MD, Shingo Yano, MD, Hiroshi Osawa, MD, Yutaka Takei, MD, Yuichi Yahagi, MD, Shinobu Takahara, MD, Yoji Ogasawara, MD, Hiroko Otsubo, MD, Yuko Yamaguchi, MD, Takeshi Saito, MD, Dai Maruyama, MD, Tatsunosuke Kobayashi, MD, Yasutaka Hoshi, MD, Noriko Usui, MD

Blood (2006) 108 (11): 5358.

https://doi.org/10.1182/blood.V108.11.5358.5358

Published: 2006

Journal Articles

Clinical Efficacy and Feasibility of an Intensive Preparative Regimen with Busulfan, Cyclophosphamide, and Total Body Irradiation Followed by Allogeneic Stem Cell Transplantation for Patients with Myeloid Malignancies.

Shingo Yano, MD, Osamu Asai, MD, Nobuaki Dobashi, MD, Hiroshi Osawa, MD, Yutaka Takei, MD, Yuichi Yahagi, MD, Shinobu Takahara, MD, Yoji Ogasawara, MD, Hiroko Otsubo, MD, Yuko Yamaguchi, MD, Jiro Minami, MD, Dai Maruyama, MD, Tatsunosuke Kobayashi, MD, Yasutaka Hoshi, MD, Noriko Usui, MD

Blood (2006) 108 (11): 5240.

https://doi.org/10.1182/blood.V108.11.5240.5240

Published: 2006

Journal Articles

Allogeneic Hematopoietic Stem Cell Transplantation after Combination Therapy with Imatinib and Intensive Chemotherapy for Newly Diagnosed Philadelphia Chromosome Positive (Ph + ) Acute Lymphoblastic Leukemia.

Noriko Usui, MD, Shingo Yano, MD, Shinobu Takahara, MD, Osamu Asai, MD, Nobuaki Dobashi, MD, Hiroshi Osawa, MD, Yutaka Takei, MD, Yoji Ogasawara, MD, Hiroko Otubo, MD, Yuko Yamaguchi, MD, Takeshi Saito, MD, Jiro Minami, MD, Ken Kaito, MD, Masayuki Kobayashi

Blood (2005) 106 (11): 5304.

https://doi.org/10.1182/blood.V106.11.5304.5304

Published: 2005

Journal Articles

Etoposide Containing Preparative Regimen for Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Acute Lymphoblastic Leukemia.

Takeshi Saito, Osamu Asai, Nobuaki Dobashi, Shingo Yano, Tamotsu Ichiba, Hiroshi Osawa, Yutaka Takei, Katuki Sugiyama, Yutaka Okawa, Sinobu Takahara, Yuko Yamaguchi, Jiro Minami, Noriko Usui, Masayuki Kobayashi

Blood (2004) 104 (11): 5034.

https://doi.org/10.1182/blood.V104.11.5034.5034

Published: 2004

NARROW

A Retrospective Comparison of Once-Daily Prolonged-Release Tacrolimus Versus Twice-Daily Tacrolimus in Allogeneic Bone Marrow Transplantation from Unrelated Donors

Antitumor Activities Of An Oral Selective HSP90α/β Inhibitor, TAS-116, In Combination With Bortezomib In Multiple Myeloma

TAS-117, a Novel Selective Akt Inhibitor Demonstrates Significant Growth Inhibition in Multiple Myeloma Cells in Vitro and in Vivo

Rational Combination Treatment of a Novel Selective mTOR Kinase Inhibitor AZD8055 with IGF-1R Inhibitors in Multiple Myeloma

Blockade of XBP1 splicing by inhibition of IRE1α is a promising therapeutic option in multiple myeloma

Immunomodulatory Effects of Histone Deacetylase 6 Inhibition in Suppressor Immune Cells in Multiple Myeloma

Blockade of XBP1 Splicing by Inhibition of IRE1α Is a Promising Therapeutic Option in Multiple Myeloma

Dual Inhibition of Canonical and Non-Canonical NF-KB Pathway Demonstrates Significant Anti-Tumor Activities in Multiple Myeloma (MM)

DEPTOR Is a Regulator of Response to mTOR Kinase Inhibitors in Multiple Myeloma

Single-Institute Comparable Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation from Unrelated and Related Donor in Patients with Myeloid Malignancies.

Role of Intensive Conditioning Regimens Followed by Allogeneic Stem Cell Transplantation in Patients with Acute Lymphoblastic Leukemia: A Long-Term Follow-Up.

Clinical Efficacy and Feasibility of an Intensive Preparative Regimen with Busulfan, Cyclophosphamide, and Total Body Irradiation Followed by Allogeneic Stem Cell Transplantation for Patients with Myeloid Malignancies.

Allogeneic Hematopoietic Stem Cell Transplantation after Combination Therapy with Imatinib and Intensive Chemotherapy for Newly Diagnosed Philadelphia Chromosome Positive (Ph + ) Acute Lymphoblastic Leukemia.

Etoposide Containing Preparative Regimen for Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Acute Lymphoblastic Leukemia.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only